Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A phase I trial of the MEK inhibitor selumetinib (AZD6244... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
0
Authors
Anuradha Banerjee
20 more
Anuradha Banerjee
•
Regina Jakacki
18 more
•
Maryam Fouladi
Published
February 22, 2017
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Neuro-Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Ophthalmology
Gastroenterology
Show all topics
DOI
10.1093/neuonc/now282
